INSP - Inspire Medical Systems, Inc.

NYSE - Nasdaq Real-time price. Currency in USD
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
407,856
407,856
233,394
115,381
82,050
Cost of revenue
66,115
66,115
33,279
17,623
13,643
Gross profit
341,741
341,741
200,115
97,758
68,407
Operating expenses
Research development
68,645
68,645
37,350
26,092
12,839
Selling general and administrative
320,688
320,688
202,615
127,874
90,465
Total operating expenses
389,333
389,333
239,965
153,966
103,304
Operating income or loss
-47,592
-47,592
-39,850
-56,208
-34,897
Interest expense
1,677
1,677
2,128
2,117
2,119
Total other income/expenses net
-49
-49
-117
145
12
Income before tax
-44,268
-44,268
-41,970
-57,088
-33,203
Income tax expense
613
613
72
115
40
Income from continuing operations
-44,881
-44,881
-42,042
-57,203
-33,243
Net income
-44,881
-44,881
-42,042
-57,203
-33,243
Net income available to common shareholders
-44,881
-44,881
-42,042
-57,203
-33,243
Basic EPS
-
-1.60
-1.54
-2.19
-1.40
Diluted EPS
-
-1.60
-1.54
-2.19
-1.40
Basic average shares
-
28,072
27,263
26,073
23,804
Diluted average shares
-
28,072
27,263
26,073
23,804
EBITDA
-
-42,591
-39,842
-54,971
-31,084